ANAlto Neuroscience, Inc. ANRO · NYSE
$22.85 +4.12% (+$0.91)
- Market cap
- $896.5M
- Enterprise value
- $659.8M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- -
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- 18.4%
- Gross margin
- -
- Net margin
- -
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.16
- Free float
- 90.6%
About the company
ANRO is a Czech company founded in 1993, specializing in the production and sale of a wide range of building materials, particularly insulation and waterproofing systems. ANRO focuses on innovative technologies that improve energy efficiency and extend the lifespan of buildings. The company holds a strong position in the Czech market and also operates in several other European markets, where it has built a reputation as a high-quality and reliable supplier of construction materials.
Sector
Healthcare
Industry
Biotechnology
CEO
Amit Etkin
Employees
68
Headquarters
Mountain View
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number